Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Post

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Antimicrobial Chemotherapy|June 1, 1991
Problems with Iso-Sensitest agarD E Post, E Y Bridson
Gene Therapy|January 23, 2002
Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cellsD E Post, E G Van Meir
Neuromolecular Medicine|April 12, 2013
Epidermal growth factor receptor as a therapeutic target in glioblastomaB Kalman, E Szep, F Garzuly, et al.
International Journal of Food Microbiology|June 1, 1995
Culture media for the isolation of campylobactersJ E Corry, D E Post, P Colin, et al.
Gene Therapy|July 29, 2010
Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacyT Cherry, S L Longo, Z Tovar-Spinoza, et al.
Cancer Gene Therapy|October 9, 2010
Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoterS L Longo, C Griffith, A Glass, et al.
Gene Therapy|May 14, 2004
Tumor-specific gene expression using the survivin promoter is further increased by hypoxiaL Yang, Z Cao, F Li, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Antimicrobial Chemotherapy|June 1, 1991
Problems with Iso-Sensitest agarD E Post, E Y Bridson
Gene Therapy|January 23, 2002
Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cellsD E Post, E G Van Meir
Neuromolecular Medicine|April 12, 2013
Epidermal growth factor receptor as a therapeutic target in glioblastomaB Kalman, E Szep, F Garzuly, et al.
International Journal of Food Microbiology|June 1, 1995
Culture media for the isolation of campylobactersJ E Corry, D E Post, P Colin, et al.
Gene Therapy|July 29, 2010
Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacyT Cherry, S L Longo, Z Tovar-Spinoza, et al.
Cancer Gene Therapy|October 9, 2010
Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoterS L Longo, C Griffith, A Glass, et al.
Gene Therapy|May 14, 2004
Tumor-specific gene expression using the survivin promoter is further increased by hypoxiaL Yang, Z Cao, F Li, et al.
Pageof 1